Feedback plc

AIM-FDBK
London Stock Exchange AIM
Healthcare Medical - Healthcare Information Services
Global Rank
#41190
Country Rank
#1037
Market Cap
8.67 M
Price
19.8
Change (%)
2.41%
Volume
2,531

Feedback plc's latest marketcap:

8.67 M

As of 07/06/2025, Feedback plc's market capitalization has reached $8.67 M. According to our data, Feedback plc is the 41190th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 8.67 M
Revenue (ttm) 1.63 M
Net Income (ttm) -4,423,749.03
Shares Out 43.81 M
EPS (ttm) -0.33
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 09/16/2025
Market Cap Chart
Data Updated: 07/06/2025

Feedback plc's yearly market capitalization.

Feedback plc has seen its market value grow from £2.96 M to £8.67 M since 2014, representing a total increase of 193.36% and an annual compound growth rate (CAGR) of 10.78%.
Date Market Cap Change (%) Global Rank
07/06/2025 £8.67 M -20.55% 41190
12/31/2024 £8 M -11.16% 37995
12/29/2023 £9 M -30.77% 36498
12/30/2022 £13 M -44.29% 33877
12/31/2021 £23.34 M 103.46% 30301
12/31/2020 £11.47 M 112.42% 30533
12/31/2019 £5.4 M 11.27% 29853
12/31/2018 £4.85 M 2.84% 29205
12/29/2017 £4.72 M 1.49% 28640
12/30/2016 £4.65 M 30.44% 26586

Company Profile

About Feedback plc

Feedback plc is a medical imaging technology company specializing in software and systems designed for professionals in the medical imaging field.

Key Products & Solutions

  • Bleepa: A secure clinical communications and data viewing platform for sharing clinical-grade medical images.
  • CareLocker: A patient-centric cloud architecture enabling secure data portability.
  • Bleepa Box: Technology for sharing DICOM images and clinical data over mobile networks, integrated with CareLocker for display and review in Bleepa.
  • Cadran: A picture archiving, storage, management, and display system for medical images.
  • TexRAD: A patented algorithm for extracting and quantifying texture features in medical images.
  • TexRAD Lung: A specialized software tool for lung cancer analysis in clinical settings.

Company Background

Feedback plc was founded in 1958 and is headquartered in London, United Kingdom.

Frequently Asked Questions

  • What is Feedback plc's (AIM-FDBK) current market cap?
    As of 07/06/2025, Feedback plc (including the parent company, if applicable) has an estimated market capitalization of $8.67 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Feedback plc global market capitalization ranking is approximately 41190 as of 07/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.